Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Oral Human Insulin Enteric Coated Capsules vs Injection in Healthy Chinese Males
NCT06901726Phase 1Not yet recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Mar 2025
- Primary completion
- Apr 2025
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 1, randomised, open-label trial of human insulin in diabetes mellitus (DM) (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoints: Maximum Glucose Infusion Rate, Time to Maximum Glucose Infusion Rate and 1 more. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
human insulin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT06901726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06901726.